SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-21-006819
Filing Date
2021-03-25
Accepted
2021-03-25 16:36:32
Documents
10

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 732150
2 ex5-1.htm EX-5.1 35835
3 ex5-1_001.jpg GRAPHIC 1926
4 ex23-1.htm EX-23.1 3525
5 ex23-2.htm EX-23.2 3321
6 ex23-3.htm EX-23.3 3317
7 forms-3_001.jpg GRAPHIC 3710
8 forms-3_002.jpg GRAPHIC 3710
9 forms-3_003.jpg GRAPHIC 4655
10 forms-3_004.jpg GRAPHIC 13546
  Complete submission text file 0001493152-21-006819.txt   817796
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254698 | Film No.: 21772865
SIC: 2835 In Vitro & In Vivo Diagnostic Substances